| 臺大學術典藏 |
2020-07-03T08:45:48Z |
Role of twist in head and neck carcinoma with lymph node metastasis
|
DA-LIANG OU; Chien H.-F; Chen C.-L; Lin T.-C; Lin L.-I. |
| 臺大學術典藏 |
2020-07-03T08:45:47Z |
Induction of DNA damage-inducible gene GADD45�] contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Chen K.-F; Yu S.-L; Da-Liang Ou;Shen Y.-C;Yu S.-L;Chen K.-F;Yeh P.-Y;Fan H.-H;Feng W.-C;Wang C.-T;Lin L.-I;Hsu C;Cheng A.-L.; DA-LIANG OU; Shen Y.-C; Yeh P.-Y; Fan H.-H; Feng W.-C; Wang C.-T; Lin L.-I; Hsu C; Cheng A.-L. |
| 臺大學術典藏 |
2020-07-03T08:45:47Z |
CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
|
Lin T.-C; Hou H.-A; Chou W.-C; DA-LIANG OU; Yu S.-L; Tien H.-F; Lin L.-I.; Lin T.-C ;Hou H.-A ;Chou W.-C ;Da-Liang Ou ;Yu S.-L ;Tien H.-F ;Lin L.-I. |
| 臺大學術典藏 |
2020-07-03T08:45:44Z |
MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine
|
Lu J.-W;Lin Y.-M;Lai Y.-L;Chen C.-Y;Hu C.-Y;Tien H.-F;Da-Liang Ou;Lin L.-I.; Lu J.-W; Lin Y.-M; Lai Y.-L; Chen C.-Y; Hu C.-Y; Tien H.-F; DA-LIANG OU; Lin L.-I. |
| 臺大學術典藏 |
2020-07-03T08:45:44Z |
Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Feng Z.-R; Liou J.-Y; Fan H.-H; Lee B.-S; Hsu C; Cheng A.-L.Ann-Lii; Lin L.-I; Shyue S.-K; Da-Liang Ou;Shyue S.-K;Lin L.-I;Feng Z.-R;Liou J.-Y;Fan H.-H;Lee B.-S;Hsu C;Cheng A.-L.Ann-Lii; DA-LIANG OU |
| 臺大學術典藏 |
2020-07-03T08:45:43Z |
Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD)
|
Lu J.-W;Wang A.-N;Liao H.-A;Chen C.-Y;Hou H.-A;Hu C.-Y;Tien H.-F;Da-Liang Ou;Lin L.-I.; Lu J.-W; Wang A.-N; Liao H.-A; Chen C.-Y; Hou H.-A; Hu C.-Y; Tien H.-F; DA-LIANG OU; Lin L.-I. |
| 臺大學術典藏 |
2020-07-01T07:39:38Z |
Deoxyinosine repair in nuclear extracts of human cells
|
Lee C.-C.;Yang Y.-C.;Goodman S.D.;Chen S.;Huang T.-Y.;Cheng W.-C.;Lin L.-I.;Woei-Horng Fang; Lee C.-C.; Yang Y.-C.; Goodman S.D.; Chen S.; Huang T.-Y.; Cheng W.-C.; Lin L.-I.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:38Z |
MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia
|
Ko Y.-C.;Woei-Horng Fang;Lin T.-C.;Hou H.-A.;Chen C.-Y.;Tien H.-F.;Lin L.-I.; Ko Y.-C.; WOEI-HORNG FANG; Lin T.-C.; Hou H.-A.; Chen C.-Y.; Tien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2020-07-01T07:39:37Z |
Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis
|
Su K.-Y.;Goodman S.D.;Lai H.-M.;Yen R.-S.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Woei-Horng Fang; Su K.-Y.; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:37Z |
DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo
|
Su K.-Y.;Lin L.-I.;Goodman S.D.;Yen R.-S.;Wu C.-Y.;Chang W.-C.;Yang Y.-C.;Cheng W.-C.;Woei-Horng Fang; Su K.-Y.; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; Yang Y.-C.; Cheng W.-C.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:37Z |
Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay
|
Su K.-Y.;Lai H.-M.;Goodman S.D.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Woei-Horng Fang; Su K.-Y.; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:36Z |
Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay
|
Chang H.-L.;Su K.-Y.;Goodman S.D.;Chou N.-A.;Lin K.-C.;Cheng W.-C.;Lin L.-I.;Chang S.-Y.;Woei-Horng Fang; Chang H.-L.; Su K.-Y.; Goodman S.D.; Chou N.-A.; Lin K.-C.; Cheng W.-C.; Lin L.-I.; Chang S.-Y.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-06-30T08:09:57Z |
Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay
|
Lin L.-I.; Yang Y.-C.; Fang W.-H.; Kang-Yi Su;Lai H.-M.;Goodman S.D.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Fang W.-H.; KANG-YI SU; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis
|
Kang-Yi Su;Goodman S.D.;Lai H.-M.;Yen R.-S.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Fang W.-H.; KANG-YI SU; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo
|
Kang-Yi Su;Lin L.-I.;Goodman S.D.;Yen R.-S.;Wu C.-Y.;Chang W.-C.;Yang Y.-C.;Cheng W.-C.;Fang W.-H.; KANG-YI SU; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; Yang Y.-C.; Cheng W.-C.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay
|
Chang H.-L.;Kang-Yi Su;Goodman S.D.;Chou N.-A.;Lin K.-C.;Cheng W.-C.;Lin L.-I.;Chang S.-Y.;Fang W.-H.; Chang H.-L.; KANG-YI SU; Goodman S.D.; Chou N.-A.; Lin K.-C.; Cheng W.-C.; Lin L.-I.; Chang S.-Y.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-19T02:38:33Z |
Deoxyinosine repair in nuclear extracts of human cells
|
Lee C.-C.;Ya-Chien Yang;Goodman S.D.;Chen S.;Huang T.-Y.;Cheng W.-C.;Lin L.-I.;Fang W.-H.; Lee C.-C.; YA-CHIEN YANG; Goodman S.D.; Chen S.; Huang T.-Y.; Cheng W.-C.; Lin L.-I.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-19T02:38:32Z |
Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay
|
Su K.-Y.;Lai H.-M.;Goodman S.D.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Ya-Chien Yang;Fang W.-H.; Su K.-Y.; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; YA-CHIEN YANG; Fang W.-H. |
| 臺大學術典藏 |
2020-06-19T02:38:31Z |
Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis
|
Su K.-Y.; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; YA-CHIEN YANG; Fang W.-H.; Su K.-Y.;Goodman S.D.;Lai H.-M.;Yen R.-S.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Ya-Chien Yang;Fang W.-H. |
| 臺大學術典藏 |
2020-06-19T02:38:31Z |
DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo
|
Su K.-Y.;Lin L.-I.;Goodman S.D.;Yen R.-S.;Wu C.-Y.;Chang W.-C.;Ya-Chien Yang;Cheng W.-C.;Fang W.-H.; Su K.-Y.; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; YA-CHIEN YANG; Cheng W.-C.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-18T08:25:49Z |
Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay
|
Chang H.-L.;Su K.-Y.;Goodman S.D.;Chou N.-A.;Lin K.-C.;Cheng W.-C.;Lin L.-I.;Sui-Yuan Chang;Fang W.-H.; Chang H.-L.; Su K.-Y.; Goodman S.D.; Chou N.-A.; Lin K.-C.; Cheng W.-C.; Lin L.-I.; SUI-YUAN CHANG; Fang W.-H. |
| 臺大學術典藏 |
2020-06-17T03:01:53Z |
Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Ou D.-L.;Shen Y.-C.;Sung-Liang Yu;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Hsu C.;Cheng A.-L.; Ou D.-L.; Shen Y.-C.; SUNG-LIANG YU; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2020-06-17T03:01:52Z |
CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
|
Lin T.-C. ;Hou H.-A. ;Chou W.-C. ;Ou D.-L. ;Sung-Liang Yu ;Tien H.-F. ;Lin L.-I.; Lin T.-C.; Hou H.-A.; Chou W.-C.; Ou D.-L.; SUNG-LIANG YU; Tien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2020-04-16T02:34:21Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsay, W.; Chen, C.-Y.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Lin, C.-T.; Wu, S.-J.; Lin, L.-I.; Liu, C.-W.; Tsai, C.-H.;Hou, H.-A.;Tang, J.-L.;Kuo, Y.-Y.;Chiu, Y.-C.;Lin, C.-C.;Liu, C.-Y.;Tseng, M.-H.;Lin, T.-Y.;Liu, M.-C.;Liu, C.-W.;Lin, L.-I.;Yao, M.;Li, C.-C.;Huang, S.-Y.;Ko, B.-S.;Hsu, S.-C.;Lin, C.-T.;Wu, S.-J.;Chen, C.-Y.;Tsay, W.;Chuang, E.Y.;Chou, W.-C.;Tien, H.-F.; Tsai, C.-H.; Hou, H.-A.; Tang, J.-L.; Kuo, Y.-Y.; Chiu, Y.-C.; Lin, C.-C.; Liu, C.-Y.; Tseng, M.-H.; Lin, T.-Y.; Liu, M.-C.; Chuang, E.Y.; Chou, W.-C.; Tien, H.-F.; ERIC YAO-YU CHUANG |
| 臺大學術典藏 |
2020-04-10T12:51:17Z |
Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Shen Y.-C.; Ou D.-L.; Ou D.-L.;Shen Y.-C.;Yu S.-L.;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Chiun Hsu;Cheng A.-L.; Cheng A.-L.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Chiun Hsu; Chen K.-F.; Yu S.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
|
Ou D.-L.; Lee B.-S.; Chang Y.-C.; Lin L.-I.; Liou J.-Y.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:08Z |
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin
|
Ou D.-L.;Lee B.-S.;Lin L.-I.;Liou J.-Y.;Liao S.-C.;Chiun Hsu;Cheng A.-L.; Ou D.-L.; Lee B.-S.; Lin L.-I.; Liou J.-Y.; Liao S.-C.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:06Z |
Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou D.-L.;Shyue S.-K.;Lin L.-I.;Feng Z.-R.;Liou J.-Y.;Fan H.-H.;Lee B.-S.;Chiun Hsu;Cheng A.-L.Ann-Lii; Ou D.-L.; Shyue S.-K.; Lin L.-I.; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; Chiun Hsu; Cheng A.-L.Ann-Lii |
| 臺大學術典藏 |
2020-04-10T12:51:06Z |
H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis
|
Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; Ou D.-L.; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; Chiun Hsu; Lin L.-I.; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y. |
| 臺大學術典藏 |
2020-04-10T12:51:03Z |
Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression
|
Chiun Hsu; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; Shao Y.-Y.; Cheng A.-L.; Ou D.-L. |
| 臺大學術典藏 |
2020-04-10T12:16:01Z |
Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression
|
Hsu C.; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; YU-YUN SHAO; Cheng A.-L.; Ou D.-L. |
| 臺大學術典藏 |
2020-03-30T03:55:55Z |
Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases
|
Lin L.-I.; Lin K.-S.; Chang J.-S.; Lin D.-T.; Lin Tsai S.-J.; SHYH-CHYI LO; Pai S.-C.; Pai S.-C.;Shyh-Chyi Lo;Lin Tsai S.-J.;Chang J.-S.;Lin D.-T.;Lin K.-S.;Lin L.-I. |
| 臺大學術典藏 |
2020-03-07T06:56:33Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2020-03-07T06:56:33Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:25Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:23Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:18Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H. |
| 臺大學術典藏 |
2020-03-07T06:42:09Z |
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression
|
Huang H.-N.;Lin M.-C.;Tseng L.-H.;Chiang Y.-C.;Lin L.-I.;Lin Y.-F.;Huang H.-Y.;Kuan-Ting Kuo; Huang H.-Y.; KUAN-TING KUO; Lin L.-I.; Lin Y.-F.; Chiang Y.-C.; Tseng L.-H.; Lin M.-C.; Huang H.-N. |
| 臺大學術典藏 |
2020-03-06T08:25:04Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
Cheng Y.-C.; Cheng M.-L.; YUNG-MING JENG; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Lin L.-I. |
| 臺大學術典藏 |
2020-03-06T08:25:01Z |
Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma
|
Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Liau J.-Y.;Yung-Ming Jeng; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:55Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Yung-Ming Jeng; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T05:26:20Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:12Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:09Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:33Z |
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression
|
Huang H.-N.; Lin M.-C.; Tseng L.-H.; Chiang Y.-C.; Lin L.-I.; Lin Y.-F.; Huang H.-Y.; KUAN-TING KUO |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Lin L.-I.; Cheng Y.-C.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
